{"gene":"GNB5","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1995,"finding":"GNB5 (Gnb5) encodes a protein with five WD-40 repeat units (beta-transducin motif) following an acidic N-terminal proline-rich domain, establishing it as a beta-transducin homolog and member of the G protein beta subunit family.","method":"cDNA cloning, sequence analysis, Northern/Southern hybridization","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct sequencing and structural characterization, single lab but multiple orthogonal methods (library screening, Northern, Southern)","pmids":["7613025"],"is_preprint":false},{"year":2000,"finding":"The flailer hybrid protein combines the N-terminal 83 amino acids of Gnb5 with the C-terminal globular tail of MyoVA; this dominant-negative protein competes with wild-type MyoVA and prevents localization of smooth endoplasmic reticulum vesicles to dendritic spines of cerebellar Purkinje cells, establishing the N-terminal Gnb5 domain as sufficient to mis-target MyoVA cargo.","method":"Genetic analysis, biochemical fractionation, exon-shuffling characterization in mouse neurological mutant","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis and biochemical localization data, replicated across biochemical and genetic approaches in a single rigorous study","pmids":["10749990"],"is_preprint":false},{"year":2016,"finding":"Loss-of-function mutations in GNB5 cause sinus-node dysfunction (bradycardia) and neurodevelopmental deficits; zebrafish gnb5 knockouts recapitulate cardiac, neurological, and ophthalmological abnormalities, establishing a direct role for GNB5 in heart-rate control, hypotonia, and vision.","method":"Zebrafish knockout, human genetic analysis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in vivo model with specific phenotypic readouts, replicated in multiple families and zebrafish","pmids":["27523599"],"is_preprint":false},{"year":2016,"finding":"The GNB5 p.S81L missense variant impairs protein expression and reduces the ability of Gβ5 to stabilize RGS complexes, resulting in deficient termination of dopamine receptor (D2) signaling.","method":"Patient-derived cell assays, protein expression analysis, G protein signaling functional assay","journal":"Genome biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional signaling assay and protein stability measurements, single lab","pmids":["27677260"],"is_preprint":false},{"year":2018,"finding":"GNB5 (Gβ5) overexpression enhances store-operated calcium entry (SOCE); this effect is STIM1-dependent (requires STIM1-ERM domain) and ORAI1-independent (ORAI1 loss-of-function mutant did not inhibit Gβ5-induced SOCE).","method":"Exogenous expression in cells, calcium imaging, dominant-negative mutant analysis","journal":"The Korean journal of physiology & pharmacology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single set of overexpression experiments, no reciprocal validation","pmids":["29719456"],"is_preprint":false},{"year":2019,"finding":"The GNB5 p.S81L variant augments acetylcholine-activated potassium current (IK,ACh) in cardiomyocytes differentiated from patient-derived hiPSCs; homozygous p.S81L hiPSC-CMs showed increased IK,ACh density and more pronounced reduction of spontaneous beating upon carbachol stimulation compared to wild-type, and the IK,ACh blocker XEN-R0703 nearly reversed the bradycardia phenotype.","method":"CRISPR/Cas9 isogenic hiPSC lines, electrophysiology (patch clamp), pharmacological rescue","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 1 / Strong — isogenic CRISPR lines, electrophysiological reconstitution, pharmacological rescue; multiple orthogonal methods in a single rigorous study","pmids":["31208990"],"is_preprint":false},{"year":2019,"finding":"GNB5 loss-of-function (homozygous null p.Tyr344*) causes a dual retinal signaling defect: absent rod photoreceptor responses and a cone phototransduction recovery deficit, consistent with disrupted ON-bipolar and rod signaling pathways.","method":"Full-field electroretinography (extended protocol) with genetic confirmation by whole-exome sequencing","journal":"Documenta ophthalmologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional ERG phenotyping with defined null variant, single patient but rigorous protocol","pmids":["31720979"],"is_preprint":false},{"year":2021,"finding":"A GNB5 missense variant (p.Leu307Arg) preserves GNB5S protein expression in patient fibroblasts but abolishes function of reconstituted Gβ5S-RGS complexes in deactivating D2 dopamine receptor activity, as measured by bioluminescence resonance energy transfer (BRET) assay.","method":"Patient-derived fibroblast assay, BRET-based functional assay with reconstituted Gβ5S-RGS complexes","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BRET reconstitution assay with variant protein, single lab","pmids":["34573334"],"is_preprint":false},{"year":2025,"finding":"Gnb5 interacts directly with BACE1 (the rate-limiting enzyme for Aβ generation from APP) and negatively regulates BACE1 expression and Aβ production; the first WD domain of Gnb5 and the Ser81 residue are required for this regulation, as expression of the WD domain alone reduces Aβ deposition in 5xFAD mice, while the S81L point mutation abolishes this effect.","method":"Co-immunoprecipitation, AAV-mediated overexpression/conditional knockout in mice, domain-deletion and point-mutation analysis, Aβ deposition quantification","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP identifying direct BACE1 interaction, in vivo KO and OE with functional readout, domain mutagenesis; multiple orthogonal methods in single rigorous study","pmids":["40587559"],"is_preprint":false}],"current_model":"GNB5 encodes Gβ5, an atypical G protein β subunit with WD-40 repeats that constitutively associates with RGS proteins to deactivate GPCR signaling (including D2 dopamine and muscarinic/cholinergic pathways); loss of function augments acetylcholine-activated IK,ACh current causing bradycardia, impairs RGS-mediated termination of dopamine signaling, and disrupts retinal phototransduction recovery, while Gβ5 also directly interacts with BACE1 via its first WD domain (requiring Ser81) to negatively regulate APP processing and Aβ generation."},"narrative":{"mechanistic_narrative":"GNB5 encodes Gβ5, an atypical G protein β subunit defined by five WD-40 repeats and an acidic, proline-rich N-terminal domain [PMID:7613025], that serves as an obligate partner stabilizing RGS protein complexes to terminate G protein-coupled receptor signaling [PMID:27677260, PMID:34573334]. By stabilizing Gβ5–RGS complexes, it drives deactivation of D2 dopamine receptor signaling, and pathogenic variants that preserve protein expression yet abolish complex function (p.Leu307Arg) or that destabilize the protein (p.S81L) produce deficient signal termination [PMID:27677260, PMID:34573334]. Loss of function in humans causes a multisystem disorder of sinus-node dysfunction (bradycardia) with neurodevelopmental and ophthalmological deficits, recapitulated in zebrafish knockouts [PMID:27523599]. Mechanistically, the cardiac phenotype reflects augmented acetylcholine-activated potassium current (IK,ACh) in patient-derived cardiomyocytes, which is reversed by IK,ACh blockade [PMID:31208990], while null alleles disrupt rod and cone phototransduction recovery in the retina [PMID:31720979]. Beyond canonical GPCR regulation, Gβ5 interacts directly with BACE1 through its first WD domain in a Ser81-dependent manner to negatively regulate BACE1 expression and Aβ production, with expression of the WD domain alone reducing Aβ deposition in 5xFAD mice [PMID:40587559]. The N-terminal domain of Gβ5 is independently sufficient, when fused to MyoVA, to mis-target cargo in cerebellar Purkinje cells [PMID:10749990].","teleology":[{"year":1995,"claim":"Establishing the protein architecture of GNB5 was the first step in defining it as a divergent member of the G protein β subunit family rather than a canonical Gβ.","evidence":"cDNA cloning and sequence analysis revealing five WD-40 repeats and an acidic proline-rich N-terminus","pmids":["7613025"],"confidence":"Medium","gaps":["Does not establish a functional partner or signaling role","No biochemical activity demonstrated"]},{"year":2000,"claim":"The Gβ5 N-terminal domain was shown to carry cargo-targeting determinants, indicating function beyond the WD-40 core.","evidence":"Genetic and biochemical analysis of the flailer hybrid (Gnb5 N-terminus fused to MyoVA tail) in mouse Purkinje cells","pmids":["10749990"],"confidence":"High","gaps":["The hybrid is an engineered dominant-negative; native Gβ5 cargo-trafficking role not established","Mechanism by which the N-terminus directs MyoVA unclear"]},{"year":2016,"claim":"Human loss-of-function genetics and a zebrafish model defined GNB5 as causative for a multisystem disorder, linking it to heart-rate control, neurodevelopment, and vision.","evidence":"Human genetic analysis of multiple families plus zebrafish gnb5 knockout phenotyping","pmids":["27523599"],"confidence":"High","gaps":["Molecular mechanism linking loss of function to each organ phenotype not resolved in this study","Tissue-specific effector pathways not dissected"]},{"year":2016,"claim":"Connecting a specific patient variant to defective RGS stabilization tied the disorder to impaired GPCR signal termination, identifying the molecular consequence of mutation.","evidence":"Patient-derived cell assays and G protein signaling functional readouts for the p.S81L variant on D2 receptor deactivation","pmids":["27677260"],"confidence":"Medium","gaps":["Single lab; reciprocal validation limited","Which RGS partners are most affected not delineated"]},{"year":2018,"claim":"An overexpression study probed whether Gβ5 modulates store-operated calcium entry, proposing a STIM1-dependent, ORAI1-independent role.","evidence":"Exogenous expression with calcium imaging and dominant-negative mutant analysis","pmids":["29719456"],"confidence":"Low","gaps":["Single set of overexpression experiments without reciprocal validation","Endogenous relevance and physiological context not established","Mechanism connecting Gβ5 to STIM1 not defined"]},{"year":2019,"claim":"Isogenic patient-derived cardiomyocytes pinpointed augmented IK,ACh as the electrophysiological basis of GNB5-associated bradycardia and demonstrated pharmacological reversibility.","evidence":"CRISPR isogenic hiPSC-CM lines, patch-clamp electrophysiology, and rescue with the IK,ACh blocker XEN-R0703","pmids":["31208990"],"confidence":"High","gaps":["In vitro cardiomyocyte model; in vivo validation of pharmacological rescue not shown","Link between RGS deactivation defect and IK,ACh density not fully mechanistic"]},{"year":2019,"claim":"ERG phenotyping of a null patient resolved the retinal defect as combined rod loss and cone recovery failure, implicating GNB5 in phototransduction termination.","evidence":"Full-field electroretinography with whole-exome confirmation of the p.Tyr344* null allele","pmids":["31720979"],"confidence":"Medium","gaps":["Single patient","Specific RGS effector in retinal pathways not identified"]},{"year":2021,"claim":"A variant that preserves protein but abolishes complex function separated expression from activity, confirming that Gβ5's essential role is functional RGS-complex assembly for D2 deactivation.","evidence":"Patient fibroblast assay and BRET-based reconstitution of Gβ5S-RGS complexes with the p.Leu307Arg variant","pmids":["34573334"],"confidence":"Medium","gaps":["Single lab","Which native RGS partner mediates the defect not specified"]},{"year":2025,"claim":"Identification of a direct Gβ5–BACE1 interaction extended Gβ5 function beyond GPCR signaling into negative regulation of amyloidogenic APP processing.","evidence":"Co-IP, AAV overexpression and conditional knockout in mice, domain-deletion and point-mutation (WD1, Ser81) analysis with Aβ deposition readout in 5xFAD mice","pmids":["40587559"],"confidence":"High","gaps":["Structural basis of the WD1–BACE1 contact not resolved","Mechanism by which Gβ5 lowers BACE1 expression unclear","Relationship between this role and RGS-complex function not integrated"]},{"year":null,"claim":"How a single Gβ5 protein coordinates RGS-mediated GPCR deactivation, BACE1 regulation, and N-terminal cargo determinants within and across tissues remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model linking the WD-40 core, N-terminus, and partner interfaces","Tissue-specific effector logic for cardiac vs retinal vs neuronal phenotypes not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,7]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,7]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,7]}],"complexes":["Gβ5-RGS complex"],"partners":["RGS","BACE1","MYO5A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O14775","full_name":"Guanine nucleotide-binding protein subunit beta-5","aliases":["Gbeta5","Transducin beta chain 5"],"length_aa":395,"mass_kda":43.6,"function":"Enhances GTPase-activating protein (GAP) activity of regulator of G protein signaling (RGS) proteins, such as RGS7 and RGS9, hence involved in the termination of the signaling initiated by the G protein coupled receptors (GPCRs) by accelerating the GTP hydrolysis on the G-alpha subunits, thereby promoting their inactivation (PubMed:27677260). Increases RGS7 GTPase-activating protein (GAP) activity, thereby regulating mood and cognition (By similarity). Increases RGS9 GTPase-activating protein (GAP) activity, hence contributes to the deactivation of G protein signaling initiated by D(2) dopamine receptors (PubMed:27677260). May play an important role in neuronal signaling, including in the parasympathetic, but not sympathetic, control of heart rate (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/O14775/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNB5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"FKBP8","stoichiometry":0.2},{"gene":"GNB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/GNB5","total_profiled":1310},"omim":[{"mim_id":"617182","title":"LODDER-MERLA SYNDROME, TYPE 2, WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT CARDIAC ARRHYTHMIA; LDMLS2","url":"https://www.omim.org/entry/617182"},{"mim_id":"617173","title":"LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA; LDMLS1","url":"https://www.omim.org/entry/617173"},{"mim_id":"615004","title":"LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 3; LRIT3","url":"https://www.omim.org/entry/615004"},{"mim_id":"610890","title":"REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP","url":"https://www.omim.org/entry/610890"},{"mim_id":"607814","title":"REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP","url":"https://www.omim.org/entry/607814"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"},{"location":"Centrosome","reliability":"Additional"},{"location":"Rods & Rings","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"retina","ntpm":111.3}],"url":"https://www.proteinatlas.org/search/GNB5"},"hgnc":{"alias_symbol":["GB5"],"prev_symbol":[]},"alphafold":{"accession":"O14775","domains":[{"cath_id":"-","chopping":"11-45","consensus_level":"medium","plddt":82.3674,"start":11,"end":45},{"cath_id":"2.130.10.10","chopping":"93-393","consensus_level":"high","plddt":96.8261,"start":93,"end":393}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14775","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14775-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14775-F1-predicted_aligned_error_v6.png","plddt_mean":94.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNB5","jax_strain_url":"https://www.jax.org/strain/search?query=GNB5"},"sequence":{"accession":"O14775","fasta_url":"https://rest.uniprot.org/uniprotkb/O14775.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14775/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14775"}},"corpus_meta":[{"pmid":"27523599","id":"PMC_27523599","title":"GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27523599","citation_count":56,"is_preprint":false},{"pmid":"12401210","id":"PMC_12401210","title":"Monosialyl-Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF-7 cells defines their invasive properties.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12401210","citation_count":44,"is_preprint":false},{"pmid":"27677260","id":"PMC_27677260","title":"GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition.","date":"2016","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/27677260","citation_count":38,"is_preprint":false},{"pmid":"16995838","id":"PMC_16995838","title":"Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16995838","citation_count":25,"is_preprint":false},{"pmid":"10749990","id":"PMC_10749990","title":"The mouse neurological mutant flailer expresses a novel hybrid gene derived by exon shuffling between Gnb5 and Myo5a.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10749990","citation_count":24,"is_preprint":false},{"pmid":"31208990","id":"PMC_31208990","title":"Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,ACh).","date":"2019","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31208990","citation_count":22,"is_preprint":false},{"pmid":"31631344","id":"PMC_31631344","title":"The epileptology of GNB5 encephalopathy.","date":"2019","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/31631344","citation_count":15,"is_preprint":false},{"pmid":"36831001","id":"PMC_36831001","title":"Anti-Inflammatory Effects of Allocryptopine via the Target on the CX3CL1-CX3CR1 axis/GNB5/AKT/NF-κB/Apoptosis in Dextran Sulfate-Induced Mice.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36831001","citation_count":15,"is_preprint":false},{"pmid":"31720979","id":"PMC_31720979","title":"Unique retinal signaling defect in GNB5-related disease.","date":"2019","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31720979","citation_count":12,"is_preprint":false},{"pmid":"30631341","id":"PMC_30631341","title":"A NGS-Targeted Autism/ID Panel Reveals Compound Heterozygous GNB5 Variants in a Novel Patient.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30631341","citation_count":12,"is_preprint":false},{"pmid":"32477400","id":"PMC_32477400","title":"Severe Phenotype in a Patient With Homozygous 15q21.2 Microdeletion Involving BCL2L10, GNB5, and MYO5C Genes, Resembling Infantile Developmental Disorder With Cardiac Arrhythmias (IDDCA).","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32477400","citation_count":8,"is_preprint":false},{"pmid":"38354736","id":"PMC_38354736","title":"The association of GNB5 with Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function.","date":"2024","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38354736","citation_count":7,"is_preprint":false},{"pmid":"39577216","id":"PMC_39577216","title":"ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39577216","citation_count":5,"is_preprint":false},{"pmid":"32203251","id":"PMC_32203251","title":"IDDCA syndrome in a Chinese infant due to GNB5 biallelic mutations.","date":"2020","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32203251","citation_count":4,"is_preprint":false},{"pmid":"34573334","id":"PMC_34573334","title":"Extended Phenotyping and Functional Validation Facilitate Diagnosis of a Complex Patient Harboring Genetic Variants in MCCC1 and GNB5 Causing Overlapping Phenotypes.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34573334","citation_count":3,"is_preprint":false},{"pmid":"31479876","id":"PMC_31479876","title":"Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line.","date":"2019","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31479876","citation_count":2,"is_preprint":false},{"pmid":"32987464","id":"PMC_32987464","title":"[Intellectual developmental disorder with cardiac arrhythmia syndrome in a family caused by GNB5 variation and literature review].","date":"2020","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32987464","citation_count":2,"is_preprint":false},{"pmid":"7613025","id":"PMC_7613025","title":"The Gnb5 gene is a novel beta-transducin homolog transcribed from a divergent promoter located immediately upstream of the Syrian hamster p53 P1 promoter.","date":"1995","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/7613025","citation_count":2,"is_preprint":false},{"pmid":"29719456","id":"PMC_29719456","title":"Increased store-operated Ca2+ entry mediated by GNB5 and STIM1.","date":"2018","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29719456","citation_count":2,"is_preprint":false},{"pmid":"40565581","id":"PMC_40565581","title":"Mixed Segmental Uniparental Disomy of Chromosome 15q11-q1 Coexists with Homozygous Variant in GNB5 Gene in Child with Prader-Willi and Lodder-Merla Syndrome.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40565581","citation_count":1,"is_preprint":false},{"pmid":"40587559","id":"PMC_40587559","title":"Gnb5 is a negative regulator of the BACE1-mediated Aβ generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease.","date":"2025","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/40587559","citation_count":0,"is_preprint":false},{"pmid":"41382285","id":"PMC_41382285","title":"GB5, a synergistic phytotherapy for type 2 diabetes mellitus management: an integrated polyherbal approach from phytochemical profiling to network pharmacology.","date":"2025","source":"BMC complementary medicine and therapies","url":"https://pubmed.ncbi.nlm.nih.gov/41382285","citation_count":0,"is_preprint":false},{"pmid":"37994112","id":"PMC_37994112","title":"Inheritance of c.628-6G>A GNB5 hypomorphic allele uncovers another challenge in the pathogenic prediction of genomic variants.","date":"2023","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37994112","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13503,"output_tokens":2149,"usd":0.036372,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9140,"output_tokens":2970,"usd":0.059975,"stage2_stop_reason":"end_turn"},"total_usd":0.096347,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"GNB5 (Gnb5) encodes a protein with five WD-40 repeat units (beta-transducin motif) following an acidic N-terminal proline-rich domain, establishing it as a beta-transducin homolog and member of the G protein beta subunit family.\",\n      \"method\": \"cDNA cloning, sequence analysis, Northern/Southern hybridization\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct sequencing and structural characterization, single lab but multiple orthogonal methods (library screening, Northern, Southern)\",\n      \"pmids\": [\"7613025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The flailer hybrid protein combines the N-terminal 83 amino acids of Gnb5 with the C-terminal globular tail of MyoVA; this dominant-negative protein competes with wild-type MyoVA and prevents localization of smooth endoplasmic reticulum vesicles to dendritic spines of cerebellar Purkinje cells, establishing the N-terminal Gnb5 domain as sufficient to mis-target MyoVA cargo.\",\n      \"method\": \"Genetic analysis, biochemical fractionation, exon-shuffling characterization in mouse neurological mutant\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis and biochemical localization data, replicated across biochemical and genetic approaches in a single rigorous study\",\n      \"pmids\": [\"10749990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Loss-of-function mutations in GNB5 cause sinus-node dysfunction (bradycardia) and neurodevelopmental deficits; zebrafish gnb5 knockouts recapitulate cardiac, neurological, and ophthalmological abnormalities, establishing a direct role for GNB5 in heart-rate control, hypotonia, and vision.\",\n      \"method\": \"Zebrafish knockout, human genetic analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in vivo model with specific phenotypic readouts, replicated in multiple families and zebrafish\",\n      \"pmids\": [\"27523599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The GNB5 p.S81L missense variant impairs protein expression and reduces the ability of Gβ5 to stabilize RGS complexes, resulting in deficient termination of dopamine receptor (D2) signaling.\",\n      \"method\": \"Patient-derived cell assays, protein expression analysis, G protein signaling functional assay\",\n      \"journal\": \"Genome biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional signaling assay and protein stability measurements, single lab\",\n      \"pmids\": [\"27677260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GNB5 (Gβ5) overexpression enhances store-operated calcium entry (SOCE); this effect is STIM1-dependent (requires STIM1-ERM domain) and ORAI1-independent (ORAI1 loss-of-function mutant did not inhibit Gβ5-induced SOCE).\",\n      \"method\": \"Exogenous expression in cells, calcium imaging, dominant-negative mutant analysis\",\n      \"journal\": \"The Korean journal of physiology & pharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single set of overexpression experiments, no reciprocal validation\",\n      \"pmids\": [\"29719456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The GNB5 p.S81L variant augments acetylcholine-activated potassium current (IK,ACh) in cardiomyocytes differentiated from patient-derived hiPSCs; homozygous p.S81L hiPSC-CMs showed increased IK,ACh density and more pronounced reduction of spontaneous beating upon carbachol stimulation compared to wild-type, and the IK,ACh blocker XEN-R0703 nearly reversed the bradycardia phenotype.\",\n      \"method\": \"CRISPR/Cas9 isogenic hiPSC lines, electrophysiology (patch clamp), pharmacological rescue\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — isogenic CRISPR lines, electrophysiological reconstitution, pharmacological rescue; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"31208990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GNB5 loss-of-function (homozygous null p.Tyr344*) causes a dual retinal signaling defect: absent rod photoreceptor responses and a cone phototransduction recovery deficit, consistent with disrupted ON-bipolar and rod signaling pathways.\",\n      \"method\": \"Full-field electroretinography (extended protocol) with genetic confirmation by whole-exome sequencing\",\n      \"journal\": \"Documenta ophthalmologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional ERG phenotyping with defined null variant, single patient but rigorous protocol\",\n      \"pmids\": [\"31720979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A GNB5 missense variant (p.Leu307Arg) preserves GNB5S protein expression in patient fibroblasts but abolishes function of reconstituted Gβ5S-RGS complexes in deactivating D2 dopamine receptor activity, as measured by bioluminescence resonance energy transfer (BRET) assay.\",\n      \"method\": \"Patient-derived fibroblast assay, BRET-based functional assay with reconstituted Gβ5S-RGS complexes\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BRET reconstitution assay with variant protein, single lab\",\n      \"pmids\": [\"34573334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Gnb5 interacts directly with BACE1 (the rate-limiting enzyme for Aβ generation from APP) and negatively regulates BACE1 expression and Aβ production; the first WD domain of Gnb5 and the Ser81 residue are required for this regulation, as expression of the WD domain alone reduces Aβ deposition in 5xFAD mice, while the S81L point mutation abolishes this effect.\",\n      \"method\": \"Co-immunoprecipitation, AAV-mediated overexpression/conditional knockout in mice, domain-deletion and point-mutation analysis, Aβ deposition quantification\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP identifying direct BACE1 interaction, in vivo KO and OE with functional readout, domain mutagenesis; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"40587559\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNB5 encodes Gβ5, an atypical G protein β subunit with WD-40 repeats that constitutively associates with RGS proteins to deactivate GPCR signaling (including D2 dopamine and muscarinic/cholinergic pathways); loss of function augments acetylcholine-activated IK,ACh current causing bradycardia, impairs RGS-mediated termination of dopamine signaling, and disrupts retinal phototransduction recovery, while Gβ5 also directly interacts with BACE1 via its first WD domain (requiring Ser81) to negatively regulate APP processing and Aβ generation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNB5 encodes Gβ5, an atypical G protein β subunit defined by five WD-40 repeats and an acidic, proline-rich N-terminal domain [#0], that serves as an obligate partner stabilizing RGS protein complexes to terminate G protein-coupled receptor signaling [#3, #7]. By stabilizing Gβ5–RGS complexes, it drives deactivation of D2 dopamine receptor signaling, and pathogenic variants that preserve protein expression yet abolish complex function (p.Leu307Arg) or that destabilize the protein (p.S81L) produce deficient signal termination [#3, #7]. Loss of function in humans causes a multisystem disorder of sinus-node dysfunction (bradycardia) with neurodevelopmental and ophthalmological deficits, recapitulated in zebrafish knockouts [#2]. Mechanistically, the cardiac phenotype reflects augmented acetylcholine-activated potassium current (IK,ACh) in patient-derived cardiomyocytes, which is reversed by IK,ACh blockade [#5], while null alleles disrupt rod and cone phototransduction recovery in the retina [#6]. Beyond canonical GPCR regulation, Gβ5 interacts directly with BACE1 through its first WD domain in a Ser81-dependent manner to negatively regulate BACE1 expression and Aβ production, with expression of the WD domain alone reducing Aβ deposition in 5xFAD mice [#8]. The N-terminal domain of Gβ5 is independently sufficient, when fused to MyoVA, to mis-target cargo in cerebellar Purkinje cells [#1].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the protein architecture of GNB5 was the first step in defining it as a divergent member of the G protein β subunit family rather than a canonical Gβ.\",\n      \"evidence\": \"cDNA cloning and sequence analysis revealing five WD-40 repeats and an acidic proline-rich N-terminus\",\n      \"pmids\": [\"7613025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish a functional partner or signaling role\", \"No biochemical activity demonstrated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The Gβ5 N-terminal domain was shown to carry cargo-targeting determinants, indicating function beyond the WD-40 core.\",\n      \"evidence\": \"Genetic and biochemical analysis of the flailer hybrid (Gnb5 N-terminus fused to MyoVA tail) in mouse Purkinje cells\",\n      \"pmids\": [\"10749990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The hybrid is an engineered dominant-negative; native Gβ5 cargo-trafficking role not established\", \"Mechanism by which the N-terminus directs MyoVA unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Human loss-of-function genetics and a zebrafish model defined GNB5 as causative for a multisystem disorder, linking it to heart-rate control, neurodevelopment, and vision.\",\n      \"evidence\": \"Human genetic analysis of multiple families plus zebrafish gnb5 knockout phenotyping\",\n      \"pmids\": [\"27523599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking loss of function to each organ phenotype not resolved in this study\", \"Tissue-specific effector pathways not dissected\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connecting a specific patient variant to defective RGS stabilization tied the disorder to impaired GPCR signal termination, identifying the molecular consequence of mutation.\",\n      \"evidence\": \"Patient-derived cell assays and G protein signaling functional readouts for the p.S81L variant on D2 receptor deactivation\",\n      \"pmids\": [\"27677260\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; reciprocal validation limited\", \"Which RGS partners are most affected not delineated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"An overexpression study probed whether Gβ5 modulates store-operated calcium entry, proposing a STIM1-dependent, ORAI1-independent role.\",\n      \"evidence\": \"Exogenous expression with calcium imaging and dominant-negative mutant analysis\",\n      \"pmids\": [\"29719456\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single set of overexpression experiments without reciprocal validation\", \"Endogenous relevance and physiological context not established\", \"Mechanism connecting Gβ5 to STIM1 not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Isogenic patient-derived cardiomyocytes pinpointed augmented IK,ACh as the electrophysiological basis of GNB5-associated bradycardia and demonstrated pharmacological reversibility.\",\n      \"evidence\": \"CRISPR isogenic hiPSC-CM lines, patch-clamp electrophysiology, and rescue with the IK,ACh blocker XEN-R0703\",\n      \"pmids\": [\"31208990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro cardiomyocyte model; in vivo validation of pharmacological rescue not shown\", \"Link between RGS deactivation defect and IK,ACh density not fully mechanistic\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"ERG phenotyping of a null patient resolved the retinal defect as combined rod loss and cone recovery failure, implicating GNB5 in phototransduction termination.\",\n      \"evidence\": \"Full-field electroretinography with whole-exome confirmation of the p.Tyr344* null allele\",\n      \"pmids\": [\"31720979\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient\", \"Specific RGS effector in retinal pathways not identified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A variant that preserves protein but abolishes complex function separated expression from activity, confirming that Gβ5's essential role is functional RGS-complex assembly for D2 deactivation.\",\n      \"evidence\": \"Patient fibroblast assay and BRET-based reconstitution of Gβ5S-RGS complexes with the p.Leu307Arg variant\",\n      \"pmids\": [\"34573334\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Which native RGS partner mediates the defect not specified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of a direct Gβ5–BACE1 interaction extended Gβ5 function beyond GPCR signaling into negative regulation of amyloidogenic APP processing.\",\n      \"evidence\": \"Co-IP, AAV overexpression and conditional knockout in mice, domain-deletion and point-mutation (WD1, Ser81) analysis with Aβ deposition readout in 5xFAD mice\",\n      \"pmids\": [\"40587559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the WD1–BACE1 contact not resolved\", \"Mechanism by which Gβ5 lowers BACE1 expression unclear\", \"Relationship between this role and RGS-complex function not integrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single Gβ5 protein coordinates RGS-mediated GPCR deactivation, BACE1 regulation, and N-terminal cargo determinants within and across tissues remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model linking the WD-40 core, N-terminus, and partner interfaces\", \"Tissue-specific effector logic for cardiac vs retinal vs neuronal phenotypes not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 7]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 7]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 7]}\n    ],\n    \"complexes\": [\"Gβ5-RGS complex\"],\n    \"partners\": [\"RGS\", \"BACE1\", \"MYO5A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}